Investing in Community Health: A New Model for Safety-Net Healthcare Innovation
Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund as limited partners.
Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition
Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma.
Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.
The Biggest Healthcare Fix Might Not Come From a Vendor
Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to real time instead of on a vendor's roadmap.